scholarly journals Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds

Author(s):  
Konda Mani Saravanan ◽  
Haiping Zhang ◽  
Renganathan Senthil ◽  
Kevin Kumar Vijayakumar ◽  
Vignesh Sounderrajan ◽  
...  
2012 ◽  
Vol 77 (6) ◽  
pp. C710-C718 ◽  
Author(s):  
Bhaskar Sanyal ◽  
S. Chatterjee ◽  
Prasad S. Variyar ◽  
Arun Sharma

Phytomedicine ◽  
2007 ◽  
Vol 14 (2-3) ◽  
pp. 209-215 ◽  
Author(s):  
A. Veerappan ◽  
S. Miyazaki ◽  
M. Kadarkaraisamy ◽  
D. Ranganathan

Author(s):  
Muhammad Tahir ul Qamar ◽  
Safar M. Alqahtani ◽  
Mubarak A. Alamri ◽  
Ling-Ling Chen

The recent outbreak of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in December 2019 raised global health concerns. The viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme, which controls coronavirus replication and is essential for its life cycle, is a proven drug discovery target in the case of severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV). Recent studies revealed that the genome sequence of SARS-CoV-2 is very similar to that of SARS-CoV. Therefore, herein, we analysed the 3CLpro sequence, constructed a 3D homology model, and screened it against a medicinal plant library containing 32,297 potential anti-viral phytochemicals/traditional Chinese medicinal compounds. Our analyses revealed that the top nine hits may serve as potential anti- SARS-CoV-2 lead molecules for further optimisation and drug development to control COVID-19.


Author(s):  
P.L. Palatty ◽  
A.R. Shivashankara ◽  
M.S. Baliga ◽  
A. Jaiswal ◽  
P. Pankaj ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document